Donald E. Bobo, Jr. sold $1.2M worth of shares in Edwards Lifesciences Corp. in June 2018
Jul 08, 2018
Vice President-Strategy & Corporate Development at Edwards Lifesciences Corp.
In The News
Bay Labs Announces Collaboration with Edwards Lifesciences to Utilize AI Software to Improve Heart Disease Detection
Dec 10, 2018 - Business Wire
Dec 05, 2018 - PR Newswire
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..
In The News
Worldwide Interventional Cardiovascular Device (ICD) Markets to 2024 - Segmented by Type, Region, and Country
Aug 20, 2019 - PR Newswire
Aug 16, 2019 - ENP Newswire
Aug 16, 2019 - PR Newswire